ByHeart is the first new infant formula manufacturer in over 15 years to be registered with FDA, making it only the 4th vertically integrated infant formula brand in the US

ByHeart's nationwide clinical trial proved next-to-breast milk benefits. The formula includes a patented blend of the two most abundant proteins in breast milk as well as organic, grass-fed whole milk

ByHeart's formula supports all-in-one benefits including easy digestion, less spit up, and immune, gut and cognitive development, all without corn syrup, maltodextrin, soy or palm oil

ByHeart's farm to formula oversight enabled the company to become the first Clean Label Project certified infant formula in the US, at their highest tier, "The Purity Award."

NEW YORK , March 23, 2022 /PRNewswire/ -- Today ByHeart, the next-generation baby nutrition company dedicated to setting a new standard for infant nutrition, launched its highly anticipated infant formula to do better for babies and parents. ByHeart founders and siblings Ron Belldegrun and Mia Funt , both parents, realized that there have been significant modern advancements in nutrition science and breast milk research, which had not been incorporated into the infant formulas currently on the market – and the only way to truly innovate was to start from scratch, acquire their own manufacturing and R&D, source every ingredient, and apply rigorous quality standards, from farm to formula. ByHeart's team spent five years working with leading experts in breast milk research to develop the first infant formula in the US to include a patented protein blend that is closest to breast milk and the only infant formula in the US to include organic, grass-fed whole milk (as opposed to skim, used by most other formulas). ByHeart is also the first new infant formula brand on the market to demonstrate its distinct benefits through the company's own rigorous clinical trial. This revolutionary approach has yielded the first clinically proven easy-to-digest infant formula with no corn syrup, maltodextrin, soy, or palm oil – and has combined next-to-breast milk benefits and certified cleanest ingredients, so parents don't have to choose one or the other (as they do with so many other formulas on shelf today).

"At ByHeart, we believe that breast milk is nature's superfood – the world's most natural, functional nutrition – and that's why it's our blueprint. We brought together experts in every facet of breast milk research, baby health and nutrition because innovating in the infant formula category isn't about one ingredient, one benefit, or one expert," says ByHeart CEO and Co-Founder, Ron Belldegrun . "To truly innovate to our standards, we couldn't rely on existing clinical research as the industry has – for the most part – for decades: owning our manufacturing and R&D, having direct relationships with every single supplier, and finally conducting our own clinical trial has allowed us to innovate, to control every ingredient in the formula, and to get closer to breast milk in ways that will be new to the market, all for the benefit of baby's foundational health and wellness."

The proteins in breast milk are highly functional, providing benefits beyond filling tummies: they are key to supporting a strong immune system, healthy gut microbiome and easy digestion; yet the protein blend is still the largest gap between breast milk and existing formula on the shelf. By building their recipe from scratch, ByHeart was able to include lactoferrin and breast milk levels of alpha-lactalbumin (the two most abundant proteins in breast milk), as well as broken down proteins and an 80:20 whey to casein ratio that most closely mirrors colostrum, or early breast milk. This patented protein blend was tested in ByHeart's clinical trial, the largest conducted by a new infant formula entrant in over 25 years, which has shown significant next-to-breast milk benefits: easier digestion, less spit-up, and softer poops. Their trial was designed to meet and exceed the rigorous requirements set by the FDA and included a breastfed reference arm – a significant and elective addition to the study that demonstrated those benefits.

"We want parents to have full visibility into their babies' nutrition from farm to formula and feel empowered in the feeding decisions they make. We called our company ByHeart because we believe parents know their babies' needs 'by heart' – and they deserve a partner that can support them with no-compromise products and parent-centric resources, so they can feel proud of the feeding decisions they make – whatever they may be," said ByHeart President and Co-Founder, Mia Funt .

Grounded in the belief that the more you control the process, the more you can control the quality of the product and deliver superior nutrition for babies, ByHeart acquired and upgraded a manufacturing facility in Reading, PA in 2019 that is certified kosher, certified grass-fed, certified organic, and SQF-certified, and gives ByHeart the rare capability to accept fresh milk from local farms. ByHeart is the only US formula that uses organic, grass-fed whole milk (most other formulas lose some of the whole fat benefits by relying on skim milk). ByHeart's organic lactose and organic prebiotic fiber – vital ingredients for newborn babies – help keep bacteria balanced and support nutrient absorption. ByHeart's dedication to a standard of quality in sourcing and manufacturing that far exceeds industry norms is what enabled the company to become the first infant formula in the US to receive Clean Label Project certification, and moreover at the highest level – their Purity Award.

ByHeart's commitment to families goes beyond creating no-compromise nutrition products: as a fully integrated company participating in the most fundamental food category in the world, Belldegrun and Funt believe they have a responsibility to not only consider the products they are making, but also the planet the next generation will inherit. The company is dedicated to a rigorous quality program, reducing waste and carbon emissions, and developing renewable systems for a more sustainable future. They have created the first all-metal, infinitely recyclable container (including a metal cap) in infant formula.

ByHeart's infant formula is now available exclusively on byheart.com, priced at $39 for a 680g can, the equivalent of 46 four-ounce bottles. Families who are formula feeding exclusively will only need about five cans per month (as opposed to over 10 from some other brands).

Founded in 2016, based in New York City with manufacturing facilities in Pennsylvania , ByHeart is a fully integrated baby nutrition company dedicated to empowering parents with choices for a better feeding future. ByHeart is only the 4th fully integrated, FDA-registered infant formula brand in the country, and the ByHeart facility is driven by nutritional excellence and a farm-to-formula verified™ quality program. For more information on ByHeart, visit https://byheart.com/.

View original content to download multimedia:https://www.prnewswire.com/news-releases/byheart-announces-the-launch-of-its-groundbreaking-infant-formula-becoming-the-only-new-infant-formula-brand-in-decades-to-rewrite-the-recipe-from-scratch-301508471.html

Markets correspondent Jared Blikre takes a look at the declining pricing for cryptocurrencies bitcoin and ethereum as the FDIC issue letters to five crypto companies.

In the world of stock legends, George Soros stands out. While his political activities have been a lightning rod for controversy, no one can doubt his financial acumen. After all, he’s the ‘man who broke the Bank of England,’ and made a billion dollars in one day when he shorted the Pound Sterling back in 1992. His hedge fund, Soros Fund Management, showed three decades of sustained gains, averaging 30% annual returns through the year 2000. During this time, and today in the management of his pe

The stock rose as much as 272% but is up about 175% as of 1:25 p.m. ET. The tech stock's gain came on the day of its initial public offering (IPO). Given the way the stock is soaring, the market apparently thinks the IPO was underpriced.

Yahoo Finance Live co-anchor Seana Smith looks at several trending stocks moving in after-hours trading.

(Bloomberg) -- The US mortgage industry is seeing its first lenders go out of business after a sudden spike in lending rates, and the wave of failures that’s coming could be the worst since the housing bubble burst about 15 years ago. Most Read from BloombergUS Mortgage Lenders Are Starting to Go BrokeMueller Memo Advising Barr on Trump Findings Is Ordered ReleasedXi and Putin to Attend G-20 Summit in Indonesia, Jokowi SaysStocks Slide as Short-Sellers Cash In on Fedspeak: Markets WrapApple Targ

A 20-year-old USC student has made a $110 million profit from trading meme stock favorite Bed Bath & Beyond, following a frenzy in Wednesday’s trading session.

Shares of StoneCo (NASDAQ: STNE), a cloud-based technology platform, plummeted Friday morning after the company reported its second-quarter results, which disappointed investors, and announced yet another shift to its management team. The company reported non-GAAP (adjusted) earnings of 0.25 Brazilian reals (equivalent to $0.05), which was an increase from a loss of 0.48 reals in the year-ago quarter, but was below Wall Street's consensus estimate of about 0.57 reals, or $0.11 per share. StoneCo's revenue in the quarter was 2.3 billion reals (about $442 million), 5% higher than the company's guidance, and up 275% from the year-ago quarter.

Jake Freeman cashed out his 6% stake in the meme stock after it exploded on Tuesday.

BEIJING (Reuters) -A Shanghai court on Friday sentenced Chinese-Canadian billionaire Xiao Jianhua, not seen in public since 2017, to 13 years in jail and fined his Tomorrow Holdings conglomerate 55.03 billion yuan ($8.1 billion), a record in China. Xiao and Tomorrow Holdings were charged with illegally siphoning away public deposits, betraying the use of entrusted property, and the illegal use of funds and bribery, the Shanghai First Intermediate Court said. China-born Xiao, known to have links to China's Communist Party elite, was last seen whisked away in a wheelchair from a luxury Hong Kong hotel in the early hours with his head covered, a source close to the tycoon told Reuters at the time.

Back up the EV on shares of General Motors, says this one analyst.

Question: I had $225,000 in my 401(k) and then I rolled over $125,000 to an annuity at 7%, as I wanted income. Should I hire a financial adviser to help? Answer: Congrats on your impending retirement — and know that it’s totally normal to feel like now may be the time to hire a financial adviser.

If you keep money in a regular savings account you will generally owe federal income taxes on the interest that is earned. You'll pay taxes at your regular rate the year interest is earned, whether or not you withdraw from … Continue reading → The post How to Avoid Tax on a Savings Account appeared first on SmartAsset Blog.

One of the big reasons for investing in real estate investment trusts (REITs) is the kind of dividends many pay. While Treasury bonds are just beginning to catch up with inflation, some REITs offer better yields as long as investors are willing to accept the risks attached to owning them. Here are seven REITs with better-than-average, hard-to-ignore dividend yields: AGNC Investment Corp. (NASDAQ: AGNC) is paying 11.36% at a price of $12.57. The Bethesda, Maryland-based company specializes in res

Oil stocks and chemicals dominate this list of today's fastest-growing stocks, all eyeing 111%-762% EPS gains this year.

Yahoo Finance's Brian Cheung discusses reports that a depression drug from Axsome Therapeutics has gotten FDA clearance.

The Food and Drug Administration approved a new depression pill from Axsome Therapeutics on Friday, and AXSM stock catapulted higher.

Chasing best-known favorites may not be the best way to score on Meme stocks, analysts say. Meme stock ETFs can help.

Prices at the pump have fallen again, but the summer decline is mostly over, according to industry watchers.

(Bloomberg) -- Billionaire Ryan Cohen pocketed a $68.1 million profit from the sale of his stake in Bed Bath & Beyond Inc., scoring a 56% gain on an investment he held for roughly seven months.Most Read from BloombergUS Mortgage Lenders Are Starting to Go BrokeMueller Memo Advising Barr on Trump Findings Is Ordered ReleasedXi and Putin to Attend G-20 Summit in Indonesia, Jokowi SaysStocks Slide as Short-Sellers Cash In on Fedspeak: Markets WrapApple Targets Sept. 7 for iPhone 14 Launch in Flurry

Harriet Hageman says the Wyoming representative didn't actually concede after losing on Election Night, but Cheney has the receipts